Morgan L Moon1, Jennifer J Joesting2, Marcus A Lawson3, Gabriel S Chiu1, Neil A Blevins2, Kristin A Kwakwa2, Gregory G Freund4. 1. Division of Nutritional Sciences, University of Illinois, Urbana IL, USA. 2. Department of Pathology, Program in Integrative Immunology and Behavior, University of Illinois, Urbana IL, USA. 3. Department of Animal Sciences, University of Illinois, Urbana IL, USA. 4. Division of Nutritional Sciences, University of Illinois, Urbana IL, USA; Department of Pathology, Program in Integrative Immunology and Behavior, University of Illinois, Urbana IL, USA; Department of Animal Sciences, University of Illinois, Urbana IL, USA. Electronic address: freun@illinois.edu.
Abstract
OBJECTIVES: Excess fat in the diet can impact neuropsychiatric functions by negatively affecting cognition, mood and anxiety. We sought to show that the free fatty acid (FFA), palmitic acid, can cause adverse biobehaviors in mice that last beyond an acute elevation in plasma FFAs. METHODS: Mice were administered palmitic acid or vehicle as a single intraperitoneal (IP) injection. Biobehaviors were profiled 2 and 24 h after palmitic acid treatment. Quantification of dopamine (DA), norepinephrine (NE), serotonin (5-HT) and their major metabolites was performed in cortex, hippocampus and amygdala. FFA concentration was determined in plasma. Relative fold change in mRNA expression of unfolded protein response (UPR)-associated genes was determined in brain regions. RESULTS: In a dose-dependent fashion, palmitic acid rapidly reduced mouse locomotor activity by a mechanism that did not rely on TLR4, MyD88, IL-1, IL-6 or TNFα but was dependent on fatty acid chain length. Twenty-four hours after palmitic acid administration mice exhibited anxiety-like behavior without impairment in locomotion, food intake, depressive-like behavior or spatial memory. Additionally, the serotonin metabolite 5-HIAA was increased by 33% in the amygdala 24h after palmitic acid treatment. CONCLUSIONS: Palmitic acid induces anxiety-like behavior in mice while increasing amygdala-based serotonin metabolism. These effects occur at a time point when plasma FFA levels are no longer elevated.
OBJECTIVES: Excess fat in the diet can impact neuropsychiatric functions by negatively affecting cognition, mood and anxiety. We sought to show that the free fatty acid (FFA), palmitic acid, can cause adverse biobehaviors in mice that last beyond an acute elevation in plasma FFAs. METHODS:Mice were administered palmitic acid or vehicle as a single intraperitoneal (IP) injection. Biobehaviors were profiled 2 and 24 h after palmitic acid treatment. Quantification of dopamine (DA), norepinephrine (NE), serotonin (5-HT) and their major metabolites was performed in cortex, hippocampus and amygdala. FFA concentration was determined in plasma. Relative fold change in mRNA expression of unfolded protein response (UPR)-associated genes was determined in brain regions. RESULTS: In a dose-dependent fashion, palmitic acid rapidly reduced mouse locomotor activity by a mechanism that did not rely on TLR4, MyD88, IL-1, IL-6 or TNFα but was dependent on fatty acid chain length. Twenty-four hours after palmitic acid administration mice exhibited anxiety-like behavior without impairment in locomotion, food intake, depressive-like behavior or spatial memory. Additionally, the serotonin metabolite 5-HIAA was increased by 33% in the amygdala 24h after palmitic acid treatment. CONCLUSIONS:Palmitic acid induces anxiety-like behavior in mice while increasing amygdala-based serotonin metabolism. These effects occur at a time point when plasma FFA levels are no longer elevated.
Authors: Sirin Yaemsiri; Souvik Sen; Lesley F Tinker; Whitney R Robinson; Rhobert W Evans; Wayne Rosamond; Sylvia Wasserthiel-Smoller; Ka He Journal: Stroke Date: 2013-07-30 Impact factor: 7.914
Authors: Albert E Towers; Maci L Oelschlager; Michal B Juda; Sparsh Jain; Stephen J Gainey; Gregory G Freund Journal: Metabolism Date: 2019-11-05 Impact factor: 8.694
Authors: Gabriel S Chiu; Magdalena A Maj; Sahar Rizvi; Robert Dantzer; Elisabeth G Vichaya; Geoffroy Laumet; Annemieke Kavelaars; Cobi J Heijnen Journal: Cancer Res Date: 2016-11-22 Impact factor: 12.701
Authors: Morgan L Moon; Jennifer J Joesting; Neil A Blevins; Marcus A Lawson; Stephen J Gainey; Albert E Towers; Leslie K McNeil; Gregory G Freund Journal: Behav Genet Date: 2015-03-14 Impact factor: 2.805
Authors: Michael J Butler; Nicholas P Deems; Stephanie Muscat; Christopher M Butt; Martha A Belury; Ruth M Barrientos Journal: Brain Behav Immun Date: 2021-08-20 Impact factor: 7.217